A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Now, new research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized ...

Now, new research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized ...

WEDNESDAY, Nov. 6, 2024 (HealthDay News) -- A simple nasal swab might help doctors predict the severity of a person’s COVID infection, a new study suggests. More than 70% of people with mild or ...

A new nasal swab test can accurately predict the severity of COVID-19 infections. It provides a more precise prediction than currently available of how serious the case is by focusing on ...

This runs counter to blood tests, where more autoantibodies indicate a severe infection WEDNESDAY, Nov. 6, 2024 (HealthDay News) -- A simple nasal swab might help doctors predict the severity of a ...